Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07288554
PHASE1

A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Sponsor: Bambusa Therapeutics

View on ClinicalTrials.gov

Summary

This study is a randomized, double-Blind, placebo-controlled, Single- and Multiple-ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT002 in Healthy Volunteers and Participants with Chronic Obstructive Pulmonary Disease (COPD).

Official title: A Randomized, Double-Blind, Placebo-controlled, Single- and Multiple-ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT002 in Healthy Volunteers and Participants With Chronic Obstructive Pulmonary Disease (COPD)

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

68

Start Date

2025-09-05

Completion Date

2027-05-30

Last Updated

2026-01-07

Healthy Volunteers

Yes

Interventions

DRUG

BBT002

BBT002 will be administered

DRUG

Placebo

Placebo will be administered

Locations (11)

The Second Hospital of Anhui Medical Univesity

Hefei, Anhui, China

The third affiliated hosptial of Guangzhou Medical University

Guangzhou, Guangdong, China

The First Affiliated Hospital of Guangdong Medical University

Guangzhou, Guangdong, China

Jiangmen Central Hospital

Jiangmen, Guangdong, China

Qingyuan People's Hospital

Qingyuan, Guangdong, China

The First People's Hospital of Xinxiang City

Xinxiang, Henan, China

Yichang Central People's Hospital

Yichang, Hubei, China

The Affiliated Hospital of Xuzhou Medical University

Xuzhou, Jiangsu, China

Jiangxi Provincial People's Hospital

Nanchang, Jiangxi, China

Chengdu fifth People's Hospital

Chengdu, Sichuang, China

Zhejiang Provincial People's Hospital

Hangzhou, Zhejiang, China